| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.23 | 2e-07 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.23 | 4e-05 |